摘要
目的探讨药物性肝病的病因、临床特点、治疗效果及预后。方法本文对198例药物性肝病患者就诊时的肝功能、症状、体症进行分析。结果经过治疗本组DILD治愈或好转91．41％，无好转7．58％，死亡率为1．01％。结论此类患者除及时停药保肝药物治疗外，同时也提醒临床医生在抗结核及抗肿瘤治疗前应常规检查肝功能，尽量选用对肝脏损害小的药物，减少药物性肝病的发生。
Objective To study etiopathogenisis, clinical characteristic, therapeutic efficacy and prognosis of drug - induced liver disease. Method To analyze body sign , symptom and Hepatic function in 198 cases. Result The rate of curing or improving is 91.41% , the rate of inefficacy is 7.58% , the death rate is 1.01% . Conclusion The drug of damaging liver should be promptly discontinuation and liver protectant should be utilize, meanwhile , we should adopt drug of no - damaging liver and decrease rate of drug - induced liver disease in antituberculosis or antineoplaston .
